Point mutation of serine 179 in the human prolactin (PRL) affects recombinant protein expression, folding and secretion, abolishes PRL nickel (II)-binding and increases heparin binding capacities

UEDA, ERICSOARES, CARLOSWALKER, AMEAEBARTOLINI, P.2014-11-192014-11-192015-04-012014-11-192014-11-192015-04-01UEDA, ERIC; SOARES, CARLOS; WALKER, AMEAE; BARTOLINI, P. Point mutation of serine 179 in the human prolactin (PRL) affects recombinant protein expression, folding and secretion, abolishes PRL nickel (II)-binding and increases heparin binding capacities. In: RECOMBINANT PROTEIN PRODUCTION MEETING, 4th, Sept. 21-23, 2006, Barcelona, Spain. <b>Abstract...</b> Disponível em: http://repositorio.ipen.br/handle/123456789/19952.http://repositorio.ipen.br/handle/123456789/19952openAccesslthserineescherichia coligene mutationsgene recombinationmammary glandsproteolysisheparinPoint mutation of serine 179 in the human prolactin (PRL) affects recombinant protein expression, folding and secretion, abolishes PRL nickel (II)-binding and increases heparin binding capacitiesResumo de eventos científicoshttps://orcid.org/0000-0002-7982-1789